Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder	Recruiting	Not applicable	2026-08-17		NCT07552402

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Harbin Medical University	42

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Baotou Cancer Hospital	Baotou	China	3
The Affiliated Hospital of Harbin Medical University	Harbin	China	1
The First Affiliated Hospital of Qiqihar Medical College	Qiqihar	China	1
The Fourth Hospital of Hebei Medical University	Shijiazhuang	China	33
The Second Hospital of Dalian Medical University	Dalian	China	15
Zhejiang Cancer Hospital	Hangzhou	China	84